RxDoctor Payments Data

Olga Voloshina

Nurse Practitioner · Seattle, WANPI 1265429740

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250,113 of the $279,211 with a category attached, or 89.6%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $85,731 and has fallen 55.3% since, to $38,315 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$279,211in general payments, 2019–2025

Across 390 payments — averaging $715.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$279K
  • Galderma Laboratories, L.p.$24

What the payments were for

  • Consulting fees$5,4412%
  • Speaking & faculty fees$250,11390%
  • Travel & lodging$15,1885%
  • Food & beverage$8,4693%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)389$279,188
Galderma Laboratories, L.p.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$279,211 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington

Other nurse practitioner in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →